Loading [Contrib]/a11y/accessibility-menu.js
prnano
  • Menu
  • Articles
    • Communications
    • Editorials
    • Letters to the Editor
    • Perspective, Opinion, or Discussion
    • Policies
    • Research Articles
    • Reviews
    • Technical Notes
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://precisionnanomedicine.com/feed
×
Research Articles
Vol. 4, Issue 1, 2021 January 17, 2021 EDT

Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro

Guankui Wang , Hanmant Gaikwad , Mary McCarthy , Mercedes Gonzalez-Juarrero , Yue Li , Michael Armstrong , Nichole Reisdorph , Thomas Morrison , Dmitri Simberg ,
  • ace2
  • vero e6
  • in vitro
  • replication
  • covid-19
  • virus
  • niclosamide
  • lipid
  • nanoparticle
  • sars-cov-2
ccby-nc-sa-4.0 • https://doi.org/10.33218/001c.18813
prnano
Wang, Guankui, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, Nichole Reisdorph, Thomas Morrison, and Dmitri Simberg. 2021. “Lipid Nanoparticle Formulation of Niclosamide (Nano NCM) Effectively Inhibits SARS-CoV-2 Replication in Vitro.” Precision Nanomedicine 4 (1): 724–37. https://doi.org/10.33218/001c.18813.
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)
Powered by Scholastica, the modern academic journal management system